The EMA at 20: An increasing impact on the non-prescription medicines market
This article was originally published in Scrip
Executive Summary
The EU regulatory system has brought some positive results in the area of non-prescription medicines, but further progress is needed to meet the expectations of the self-care sector, says Hubertus Cranz.